Safety and Efficacy of Pagibaximab Injection in Very Low Birth Weight Neonates for Prevention of Staphylococcal Sepsis
Completed · Phase 2/Phase 3 · Has a placebo group
Conditions studied: Staphylococcal Sepsis
In brief
Evaluate the safety, PK and efficacy comparing Pagibaximab Injection to placebo in preventing staphylococcal sepsis in very low birth weight infants. 1550 infants will be enrolled prior to 48 hours of life and will be randomized 1:1 to receive active drug or placebo on study days 0, 1, 2, 9, 16, and 23.
Key facts
- Study ID
- NCT00646399
- Run by
- Biosynexus Incorporated
- People needed
- 1579
- Starts
- 2009-03-01
- Expected to finish
- 2011-05-01
- Last updated by the study team
- 2011-10-24
Who can join
Age: any, up to 0. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- In-patient at a Neonatal Intensive Care Unit (NICU)
- Informed consent obtained from the legally authorized representative
- Less than 48 hours old at the time of first infusion
- Birth weight between 600 grams and 1200 grams
- Estimated gestation age ≤33 weeks
- For multiple gestations, twins may be enrolled if they each meet the entry criteria. They will both be assigned to the same treatment group.
You may not qualify if…
- Infants with history of a hypersensitivity or severe vasomotor reaction to any antibody preparation.
- Infants with proven staphylococcal infection prior to randomization.
- Infants with a concomitant infection or other medical condition, whose participation, in the opinion of the Investigator and/or medical advisor, may create an unacceptable additional risk.
- Immunodeficiency other than due to prematurity.
- Currently receiving, recently received, or planned to receive other investigational agents that could interfere with conduct or results of this study.
- Severe congenital or chromosomal anomaly that would limit life expectancy or required corrective measures during the period of this study
- Uncontrolled seizures
Where it is running
- Biosynexus Incorporated — Gaithersburg, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.